acetic anhydride, ethanoic anhydride acetic anhydride, ethanoic anhydride
acetic anhydride, ethanoic anhydride acetic anhydride, ethanoic anhydride
bulk drugs, pharmaceutical bulk drugs
bulk drugs, pharmaceutical bulk drugs
bulk drugs, pharmaceutical bulk drugs Growth Plan
At IOLCP we view the changes needs as an inspiration to improve our existing manufacturing operations. In this fast-paced world, there is a definite need to expand operations & capabilities to keep in touch with the dynamic requirements of a widening base of customers. As an established company that has consistently delivered results in the industry & market, we are committed to enhancing the value we offer to our customers & stakeholders in terms of:
  • Growth
  • Net worth
  • Earnings per share
bulk drugs, pharmaceutical bulk drugs
bulk drugs, pharmaceutical bulk drugs
bulk drugs, pharmaceutical bulk drugs
bulk drugs, pharmaceutical bulk drugs bulk drugs, pharmaceutical bulk drugs

To maintain & sustain our growth, we have consistently adopted and implemented initiatives to expand our operations and ensure fast-paced, sustainable growth.


bulk drugs, pharmaceutical bulk drugs Chemicals Expansion
The company has planned for increasing the capacity of Acetic Acid from 50000 TPA to 66000 TPA, Ethyl Acetate from 33000 TPA to 36000 TPA & Capacity of Acetic Anhydride from 12000 TPA to 18000 TPA.



bulk drugs, pharmaceutical bulk drugs Pharma Expansion
The production capacity of Ibuprofen, which has been the stronghold of our Pharma operations. IOLCP recently boosted its Ibuprofen plant capacity to 3600 TPA from 1800 TPA and to further expand the capacity to 6000 TPA.



bulk drugs, pharmaceutical bulk drugs Co-generation Power Plant
To meet out its enhanced energy requirement and to become self reliance the company has also proposed for another captive co-generation plant with additional capacity of 13 MW in addition to the existing cogeneration plant of 4 MW capacity.



bulk drugs, pharmaceutical bulk drugs Forward Integration
The company has planned for adding two more products i.e. Mono Chloro Acetic Acid(MCA) with a capacity of 6600 TPA & Acetyl Chloride with a capacity of 4800 TPA , using Acetic Anhydride & Acetic Acid as a raw material.



bulk drugs, pharmaceutical bulk drugs Backward Integration
The company has planned for setting up plant for Iso-butyl Benzene(IBB) with a capacity of 6000 TPA which will be the raw material for the manufacturing of Ibuprofen.



bulk drugs, pharmaceutical bulk drugs Research & Development
To develop new Molecules and process development


speciality chemicals manufacturer, industrial chemicals speciality chemicals manufacturer, industrial chemicals